EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients

Takafumi Yanagisawa iD, Akihiro Matsukawa iD, Kosuke Iwatani, Yasushi Hayashida, Yohei Okada iD, Risa Kubota iD, Kiichi Kamikubo, Yuki Taneda, Hirotaka Kondo, Kagenori Ito iD, Jun Miki iD, Takahiro Kimura iD und 1 weitere

International Journal of Urology · 2026

DOI: 10.1111/iju.70634 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Takafumi Yanagisawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Urinary Bladder Neoplasms, Postoperative Complications, Cystectomy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.

Methods

We retrospectively analyzed 668 patients who underwent ERBT at five institutions. Perioperative and pathological outcomes were assessed in the overall cohort. Recurrence‐free survival (RFS) was evaluated in patients with pathologically confirmed non‐muscle‐invasive bladder cancer (NMIBC) without a history of upper tract urothelial carcinoma ( n = 551). Clinicopathological prognosticators of recurrence were identified using Cox proportional hazards regression.

Results

The median age was 73 years, and the median maximum tumor diameter was 15 mm. The median operative time and postoperative catheterization period were 48 min and 3 days, respectively. Perioperative complications occurred in 60 patients (9.0%), including eight (1.2%) with Clavien–Dindo Grade III or higher complications. Detrusor muscle was identified in 77.2% of evaluable specimens. Final pathology showed pTa, pT1, pTis, and pT2 disease in 377 (56.4%), 239 (35.8%), 16 (2.4%), and 25 patients (3.7%), respectively. With a median follow‐up of 42 months, the estimated 1‐, 2‐, and 5‐year RFS rates were 80.9%, 73.2%, and 57.1%, respectively. RFS did not differ significantly between pTa and pT1 disease (log‐rank p = 0.39). Patients presenting with recurrent tumors had a significantly higher risk of subsequent intravesical recurrence than those with primary tumors (HR 2.06, 95% CI 1.38–3.07; p < 0.001).

Conclusions

ERBT demonstrated favorable perioperative safety and acceptable oncological outcomes in this large multicenter cohort. Post‐ERBT recurrence remained strongly influenced by prior recurrence history, highlighting the importance of risk‐adapted postoperative management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalUrinary Bladder NeoplasmsPostoperative ComplicationsCystectomyHumansFemaleMaleAgedRetrospective StudiesNon-Muscle Invasive Bladder NeoplasmsAged, 80 and overDisease-Free SurvivalTransurethral Resection of BladderTreatment OutcomeMiddle AgedOperative TimeUrinary Bladder

Stichwörter der Autor:innen

bladder canceren bloc resectionnon‐muscle‐invasive bladder cancerrecurrence‐free survivaltransurethral resection

Autor:innen und Institutionen

  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Urology, National Hospital Organization Ureshino Medical Center, Saga, Japan.
  • Department of Urology, Saitama Medical Center, Saitama, Japan.
  • Department of Urology, National Hospital Organization Okayama Medical Center, Okayama, Japan.

ORCID-Profile: Takafumi Yanagisawa, Akihiro Matsukawa, Yohei Okada, Risa Kubota, Kagenori Ito, Jun Miki, Takahiro Kimura

Zitieren

APA

Yanagisawa, T., Matsukawa, A., Iwatani, K., Hayashida, Y., Okada, Y., Kubota, R., Kamikubo, K., Taneda, Y., Kondo, H., Ito, K., Miki, J., Kimura, T., & Japanese En bloc TUR (JET) Study Group (2026). Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients. International Journal of Urology. https://doi.org/10.1111/iju.70634

Vancouver

Yanagisawa T, Matsukawa A, Iwatani K, Hayashida Y, Okada Y, Kubota R, et al. Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients. International Journal of Urology. 2026. doi:10.1111/iju.70634

BibTeX
@article{Yanagisawa2026,
  author = {Yanagisawa, Takafumi and Matsukawa, Akihiro and Iwatani, Kosuke and Hayashida, Yasushi and Okada, Yohei and Kubota, Risa and Kamikubo, Kiichi and Taneda, Yuki and Kondo, Hirotaka and Ito, Kagenori and Miki, Jun and Kimura, Takahiro and Japanese En bloc TUR (JET) Study Group, Japanese En bloc TUR (JET) Study Group},
  title = {Perioperative Safety and Long‐Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real‐World Study of 668 Patients},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70634}
}
Kostenlos starten →